Chaim Sheba Medical Center
Ramat Gan, 52621, Israel
NCT Number: NCT00496925
We examine the usage of Dopamine blockers in OCD patients. We want to examine their frequency of usage, compare the course of the disease between those who receive and those who do not receive Dopamine blockers, and efficacy of the treatment.
The study will be done in two stages: 1. Collecting information the usage of Dopamine blockers from 150 OCD patients' files. 2. interviewing 60-70 patients to see the difference those who receive and those who do not receive Dopamine blockers in their current severity of disease.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Ramat Gan, 52621, Israel
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Sheba Medical Center
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01590862
Anxiety Disorders, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT02355002
Anxiety Disorders, Mental Disorders
Boston, Massachusetts, United States
View Trial DetailsNCT03918837
Anxiety Disorders, Mental Disorders
Rennes, Ille et Vilaine, France
View Trial DetailsNCT03182075
Anxiety Disorders, Behavior
Stanford, California, United States
View Trial Details